Phensuximide
From Wikipedia, the free encyclopedia
![]() |
|
Clinical data | |
---|---|
MedlinePlus | a682237 |
ATC code | N03AD02 (WHO) |
Pharmacokinetic data | |
Protein binding | 21% |
Identifiers | |
|
|
CAS Number | 86-34-0 ![]() |
PubChem (CID) | 6839 |
IUPHAR/BPS | 7612 |
DrugBank | DB00832 ![]() |
ChemSpider | 6578 ![]() |
UNII | 6WVL9C355G ![]() |
KEGG | D00508 ![]() |
ChEMBL | CHEMBL797 ![]() |
ECHA InfoCard | 100.001.513 |
Chemical and physical data | |
Formula | C11H11NO2 |
Molar mass | 189.211 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Phensuximide is an anticonvulsant in the succinimide class.
External links[edit]
- Rankin G, Cressey-Veneziano K, Wang R, Brown P (1986). "Urinary tract effects of phensuximide in the Sprague-Dawley and Fischer 344 rat.". J Appl Toxicol. 6 (5): 349–56. doi:10.1002/jat.2550060509. PMID 3772011.
![]() |
This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it. |